A tumor was considered HER2 positive if IHC 2+ staining was observed in ≥ 10% of tumor cells and ERBB2 was amplified (ERBB2/CEN17 ratio ≥ 2 or nERBB2 ≥ 4). Here, ERBB2 is linked to neoplasm.